BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains

医学 不利影响 免疫系统 免疫学 人性化鼠标 肝炎 肺炎 点头 无容量 免疫疗法 药理学 内科学 内分泌学 糖尿病
作者
James L. Weaver,Leah M. Zadrozny,Kathleen L. Gabrielson,Kenrick Semple,Katherine Shea,Kristina E. Howard
出处
期刊:Toxicological Sciences [Oxford University Press]
卷期号:169 (1): 194-208 被引量:29
标识
DOI:10.1093/toxsci/kfz045
摘要

Abstract Checkpoint inhibitors represent a new class of therapeutics in the treatment of cancer that has demonstrated remarkable clinical effectiveness. However, some patients have experienced serious immune-mediated adverse effects including pneumonitis, hepatitis, colitis, nephritis, dermatitis, encephalitis, and adrenal or pituitary insufficiency. These adverse events were not predicted by nonclinical studies. To determine if bone marrow-liver-thymus (BLT) immune humanized mice could demonstrate these adverse effects, we studied the effect of nivolumab on 2 strains of BLT-humanized mice, NOD.Cg-Prkdcscid Il2rgtm1Sug/JicTac (NOG) and NOD.Cg-Prkdcscid Il2rgtm1Sug Tg(SV40/HTLV-IL3, CSF2)10-7Jic/JicTac (NOG-EXL). Mice were treated with 2.5, 5.0, or 10.0 mg/kg nivolumab or saline twice weekly for 28 days. BLT-NOG mice had significantly reduced survival compared with BLT-NOG-EXL mice. In spite of the difference in survival, both BLT-humanized strains showed adverse reactions similar to those reported in humans, including pneumonitis and hepatitis, with nephritis, dermatitis and adrenalitis also noted in some individuals. Additional histopathologic findings included pancreatic atrophy, myositis, and osteomyelitis in some animals. T-cell activation increased with concomitant loss of PD-1 detection. These findings show that BLT immune humanized mice can demonstrate immune-mediated adverse effects of antiPD1 therapy, and may represent a model that can be used to better understand toxicity of this class of drugs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助夏颁采纳,获得10
1秒前
1秒前
可罗雀完成签到,获得积分10
1秒前
朝朝发布了新的文献求助10
1秒前
1秒前
yin发布了新的文献求助30
1秒前
体贴的青烟完成签到,获得积分10
2秒前
李白完成签到,获得积分10
3秒前
微笑的巧蕊完成签到 ,获得积分10
3秒前
xjcy应助puppy采纳,获得10
3秒前
4秒前
4秒前
朔月发布了新的文献求助10
4秒前
炙热晓露发布了新的文献求助10
4秒前
5秒前
科研通AI2S应助秋子采纳,获得10
6秒前
hhh完成签到,获得积分10
7秒前
木刻青、完成签到,获得积分10
7秒前
karulko完成签到,获得积分10
8秒前
丘比特应助ee采纳,获得10
8秒前
李海妍发布了新的文献求助10
8秒前
赵Zhao完成签到,获得积分10
8秒前
小桃子发布了新的文献求助10
9秒前
9秒前
英姑应助二二春采纳,获得10
9秒前
搜集达人应助科研通管家采纳,获得10
9秒前
脑洞疼应助科研通管家采纳,获得10
10秒前
顾矜应助科研通管家采纳,获得10
10秒前
午见千山应助科研通管家采纳,获得10
10秒前
Endlessway应助科研通管家采纳,获得10
10秒前
Ava应助科研通管家采纳,获得10
10秒前
wanci应助科研通管家采纳,获得10
10秒前
上官若男应助科研通管家采纳,获得10
10秒前
朔月完成签到,获得积分10
11秒前
杳鸢应助科研通管家采纳,获得10
11秒前
充电宝应助科研通管家采纳,获得10
11秒前
小二郎应助科研通管家采纳,获得20
11秒前
Hello应助科研通管家采纳,获得10
11秒前
华仔应助科研通管家采纳,获得10
11秒前
香蕉觅云应助科研通管家采纳,获得10
11秒前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Semiconductor Process Reliability in Practice 720
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
The Heath Anthology of American Literature: Early Nineteenth Century 1800 - 1865 Vol. B 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3228806
求助须知:如何正确求助?哪些是违规求助? 2876566
关于积分的说明 8195759
捐赠科研通 2543848
什么是DOI,文献DOI怎么找? 1374072
科研通“疑难数据库(出版商)”最低求助积分说明 646872
邀请新用户注册赠送积分活动 621509